SOD1 and Hepatic fibrosis: On the other hand, NIC treatment at 7.5 mg partially restored antioxidant levels, with GSH and SOD increasing by 143% and 156%, respectively, and reduced oxidative damage markers, with MDA and NOx decreasing by 46% and 44% relative to TAA-induced liver fibrosis group.